
Adam Thomas
@adamdavidthomas
Emerg Doc / Intensivist. FOAMite. Podcast host for @iBookCC. Passionate about medical education & innovation
ID: 2287479877
https://emcrit.org/ibcc/toc/ 12-01-2014 02:05:14
3,3K Tweet
3,3K Followers
654 Following




The PATCH Team, led by Russell Gruen, a study of pre-hospital TXA for severe trauma in adults at high risk of acute traumatic coagulopathy treated in advanced trauma systems, has been published today in NEJM. #CCR23 Here’s a summary of what we did... nejm.org/doi/full/10.10…

Have I got this right? #CCR23 #PedsICU Critical Care Reviews #PATCH Oxy-PICU #AIDICU #MERCY #CLOVERS #CRYOSTAT2trial #PROCOAG #DEVICE remap-cap #TAMEtrial UKREBOATrial #Trauma #CriticalCareTrials #EmergencyMedicine




Very excited to have the voice and brains behind IBCC podcast and Crackcast, Adam Thomas co-instruct this year's Podcast CAMP Nov 30th, Dec 7th, Dec 14th. Plus keynote speaker Salim R. Rezaie, MD of REBELCast Details @ podcastcamp.org


Thanks to CHEST for the opportunity to present high risk #PE data from #FLAME 🔥 at #CHEST2023! (Finally have a good reason to use that emoji!) FT pts w significant decreased primary outcome and in-hospital mortality (1/3) Rachel Rosovsky Robert A Lookstein MD, MHCDL






Great #AHA23 so far: AHA Research 🥸8 Trials: 8 take aways below Read the read👇👇 1/ATRESIA: Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism.


True story There have been 15 trials of tooth brushing in the ICU and those trials have demonstrated fewer pneumonias and icu deaths In JAMA Internal Medicine jamanetwork.com/journals/jamai…


Single-dose cefreiaxone to prevent VAP in ventilated acute brain injury patients Multicenter RCT with 345 pts🇫🇷 Compared to placebo, CTRX reduced VAP (14% vs 32%; HR 0·60 [0·38–0·95], p=0·03) thelancet.com/journals/lanre… SCCM Ashish K. Khanna, MD,MS,FCCP,FCCM,FASA Jose L. Pascual, MD, PhD, FRCS(C), FACS, FCCM #SCCM2024



2 RCTs testing IV vs IO vascular access in OHCA patients just published in the NEJM and concomitantly presented at #RESUS24 ERC - European Resuscitation Council ➡️ No difference in 30d survival in both trials ➡️ Higher rate of ROSC with IV access in the #PARAMEDIC3 trial 🇬🇧 nejm.org/doi/full/10.10… 🇩🇰
